Armstrong, E. J., Chen, D. C., Singh, G. D., Amsterdam, E. A., & Laird, J. R. (2015). Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia. Vascular medicine (London, England), 20(3), 237-244. https://doi.org/10.1177/1358863X15574321
Chicago-Zitierstil (17. Ausg.)Armstrong, Ehrin J., Debbie C. Chen, Gagan D. Singh, Ezra A. Amsterdam, und John R. Laird. "Angiotensin-converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Is Associated with Reduced Major Adverse Cardiovascular Events Among Patients with Critical Limb Ischemia." Vascular Medicine (London, England) 20, no. 3 (2015): 237-244. https://doi.org/10.1177/1358863X15574321.
MLA-Zitierstil (9. Ausg.)Armstrong, Ehrin J., et al. "Angiotensin-converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Is Associated with Reduced Major Adverse Cardiovascular Events Among Patients with Critical Limb Ischemia." Vascular Medicine (London, England), vol. 20, no. 3, 2015, pp. 237-244, https://doi.org/10.1177/1358863X15574321.